La Jolla, CA, United States of America

Michael P Hedrick


 

 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Carlsbad, CA (US) (2017 - 2020)
  • La Jolla, CA (US) (2018 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Michael P. Hedrick: Innovator in Neurobiology

Introduction

Michael P. Hedrick is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of neurobiology, holding a total of eight patents. His work focuses on developing small molecule agonists and inhibitors that have potential therapeutic applications.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Small molecule agonists of neurotensin receptor 1." This patent provides small molecule neurotensin receptor agonists, along with compositions and methods for their use. Another notable patent is "Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof." This invention includes compounds capable of modulating the activity of low molecular weight protein tyrosine phosphatase (LMPTP) and outlines methods for their application.

Career Highlights

Michael has worked with esteemed organizations such as the Sanford Burnham Prebys Medical Discovery Institute and the Sanford Burnham Medical Research Institute. His career has been marked by a commitment to advancing scientific knowledge and developing innovative solutions in the medical field.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues, including Anthony B. Pinkerton and Thomas D. Y. Chung. These partnerships have contributed to the success of his research and inventions.

Conclusion

Michael P. Hedrick is a distinguished inventor whose work in neurobiology has led to significant advancements in therapeutic applications. His patents reflect a deep understanding of molecular biology and a commitment to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…